Raymond James Financial Inc Intra Cellular Therapies, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 915,361 shares of ITCI stock, worth $117 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
915,361Holding current value
$117 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
387Shares Held
86.2MCall Options Held
231KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.24 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$806 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$654 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$491 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$389 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...